Bayer Opens New Research & Innovation Center in Boston-Cambridge Demonstrating Its Commitment to Precision OncologyBusiness Wire • 06/29/22
Bayer's KERENDIA® (finerenone) Receives New Recommendations From American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients With Chronic Kidney Disease Associated With Type 2 DiabetesBusiness Wire • 06/28/22
Bayer Launches Calantic™ Digital Solutions to help Address Radiology Industry ChallengesBusiness Wire • 06/28/22
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and BeyondThe Motley Fool • 05/26/22